nach oben

Diabetologia

Erschienen in:

01.05.2010 | Article

Folic acid administration reduces neointimal thickening, augments neo-vasa vasorum formation and reduces oxidative stress in saphenous vein grafts from pigs used as a model of diabetes

verfasst von: J. Bloor, N. Shukla, F. C. T. Smith, G. D. Angelini, J. Y. Jeremy

Erschienen in: Diabetologia | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

There is evidence that plasma homocysteine augments vein graft failure and that it augments both micro- and macro-angiopathy in patients with diabetes mellitus. It is therefore suggested that homocysteine may augment vein graft thickening, a major cause of vein graft failure, in diabetic patients, as well as impairing adaptive growth of a new vasa vasorum, possibly through overproduction of superoxide. In order to test these proposals, the effect of folic acid administration, which lowers plasma homocysteine, on vein graft thickening and microvessel density was studied in pigs used as a model of diabetes.

Methods

Non-ketotic hyperglycaemia was induced in Landrace pigs by intravenous injection of streptozotocin, and folic acid was fed daily for 1 month. Vein grafts were excised and the thickness of the neointima and media and microvessel density were assessed by planimetry and superoxide formation.

Results

Plasma total homocysteine was significantly reduced by folic acid in both control and diabetic pigs, whereas glucose was unchanged. Compared with controls, diabetic pigs showed increased neointimal thickness and superoxide formation and decreased adventitial microvessel density. Folic acid reduced neointimal thickness and superoxide formation and augmented microvessel density in diabetic but not in control pigs.

Conclusions

Folic acid administration reduces neointimal thickening, augments vasa vasorum neoformation and reduces oxidative stress in saphenous vein grafts from diabetic pigs. Folic acid may therefore be particularly effective in reducing vein graft failure in diabetic patients.

Mortwani JG, Topol EJ (1998) Aortocoronary saphenous vein graft disease. Pathogenesis, predisposition and prevention. Circulation 97:916–931

Varty K, Allen KE, Bell PRF, London NJM (1993) Infra-inguinal vein graft stenosis. Br J Surg 80:825–833CrossRefPubMed

Jeremy JY, Gadsdon P, Shukla N et al (2007) On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents. Biomaterials 28:895–908CrossRefPubMed

Jeremy JY, Mehta D, Bryan AJ, Lewis D, Angelini GD (1997) Platelets and saphenous vein graft failure following coronary artery bypass graft surgery. Platelets 8:295–309CrossRefPubMed

Iwama Y, Mokuno H, Yokoi H (1998) Elevated levels of plasma homocysteine related to saphenous vein graft disease after coronary artery bypass graft surgery. J Cardiol 32:357–362PubMed

Irvine C, Wilson YG, Currie IC (1996) Hyperhomocysteinaemia is a risk factor for vein graft stenosis. Eur J Vasc Endovasc Surg 12:304–309CrossRefPubMed

Jeremy JY, Shukla N, Angelini GD et al (2002) Sustained increases in homocysteine, copper and ceruloplasmin following coronary artery bypass grafting. Ann Thorac Surg 74:1553–1557CrossRefPubMed

Shukla N, Thompson CS, Angelini GD et al (2002) Homocysteine augments the reduction of endothelium dependent relaxation and cGMP formation in diabetic rabbits. Diabetologia 45:1325–1331CrossRefPubMed

Shukla N, Angelini GD, Jeremy JY (2007) Interactive effects of homocysteine and copper on angiogenesis in porcine isolated saphenous vein. Ann Thorac Surg 84:43–49CrossRefPubMed

10.

Jeremy JY, Yim AP, Wan S, Angelini GD (2002) Oxidative stress, nitric oxide and vascular disease. Cardiovasc Surg 17:324–327

11.

Jeremy JY, Rowe D, Emsley AM et al (1999) Nitric oxide and vascular smooth muscle cell proliferation. Cardiovasc Res 43:658–665CrossRefPubMed

12.

Wald DS, Law MR, Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325:1202CrossRefPubMed

13.

Schnyder G, Roffi M, Pin R et al (2001) Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345:1593–1600CrossRefPubMed

14.

Schnyder G, Roffi M, Pin R et al (2003) Effect of homocysteine-lowering therapy on restenosis after percutaneous coronary intervention for narrowings in small coronary arteries. Am J Cardiol 91:1265–1269CrossRefPubMed

15.

Shukla N, Hotston M, Persad N, Angelini GD, Jeremy JY (2009) The administration of folic acid improves erectile function and reduces intracavernosal oxidative stress in the diabetic rabbit. Br J Urol Int 103:98–103

16.

Shukla N, Greaves NS, Angelini GD, Jeremy JY (2008) Folic acid reduces intravascular oxidative stress in diabetic rabbits. Metabolism 57:774–781CrossRefPubMed

17.

Jensen-Waern M, Andersson M, Kruse R et al (2009) Effects of streptozotocin-induced diabetes in domestic pigs with focus on the amino acid metabolism. Lab Anim 43:249–254CrossRefPubMed

18.

Thompson CS (2008) Animal models of diabetes mellitus: relevance to vascular complications. Curr Pharm Des 14:309–324CrossRefPubMed

19.

Jeremy JY, Thomas AC (2010) Animal models for studying neointima formation. Curr Vasc Pharmacol (in press)

20.

Koopmans SJ, Mroz Z, Dekker R et al (2006) Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model. Metabolism 55:960–971CrossRefPubMed

21.

Mehta D, George SJ, Jeremy JY et al (1984) External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arterio-venous bypass grafting. Nat Med 4:235–239CrossRef

22.

Wan S, Yim A, Bulbulia RA et al (2004) The endothelin 1_A receptor antagonist BSF 302146 is a potent inhibitor of porcine vein graft thickening in vivo. J Thorac Cardiovasc Surg 127:1317–1322CrossRefPubMed

23.

Wan S, Shukla N, Angelini GD, Yim AP, Johnson JL, Jeremy JY (2007) Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1). J Thorac Cardiovasc Surg 134:1033–1039CrossRefPubMed

24.

Vijayan V, Shukla N, Johnson JL et al (2004) Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath. J Vasc Surg 40:1011–1019CrossRefPubMed

25.

Wan S, Arifi AA, Chan MCW et al (2006) Perivenous application of fibrin glue in porcine saphenous vein–carotid artery interposition grafts: impact on medial thickening. Eur J Cardiothorac Surg 29:742–746CrossRefPubMed

26.

Muzaffar S, Jeremy JY, Angelini GD, Stuart Smith K, Shukla N (2003) The role of the endothelium and nitric oxide synthases in modulating superoxide formation induced by endotoxin and cytokines in porcine pulmonary arteries. Thorax 58:598–604CrossRefPubMed

27.

Muzaffar S, Shukla N, Angelini GD, Jeremy JY (2005) Sildenafil citrate and sildenafil nitrate are potent inhibitors of superoxide formation and gp91^phox expression in porcine pulmonary artery endothelial cells. Br J Pharmacol 146:109–117CrossRefPubMed

28.

Muzaffar S, Shukla N, Lobo C, Angelini GD, Jeremy JY (2004) Iloprost inhibits NADPH oxidase expression and superoxide release in porcine pulmonary arteries and cells stimulated with thromboxane A₂, isoprostane F_2α and cytokines. Br J Pharmacol 141:488–496CrossRefPubMed

29.

Muzaffar S, Shukla N, Angelini GD, Jeremy JY (2005) Hypoxia simultaneously induces the expression of gp91^phox and endothelial nitric oxide synthase which promotes peroxynitrite formation in the pulmonary artery. Thorax 60:305–313CrossRefPubMed

30.

Shukla N, Maher J, Masters J, Angelini GD, Jeremy JY (2006) Does oxidative stress change ceruloplasmin from a protective to a vasculopathic risk factor? Atherosclerosis 187:238–250CrossRefPubMed

31.

Wan S, Yim A, Shukla N et al (2007) Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein grafts. J Thorac Cardiovasc Surg 133:494–500CrossRefPubMed

32.

West EJ, Guzik TJ, Black E et al (2000) Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia. Arterioscler Thromb Vasc Biol 21:189–194

33.

West NE, Qian H, Guzik TJ et al (2001) Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production. Circulation 104:1526–1532CrossRefPubMed

34.

Guzik TJ, Mussa S, Gastaldi D et al (2002) Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105:1656–1662CrossRefPubMed

35.

Mangoni AA, SherWood RA, Asonganyi B, Swift CG, Thomas S, Jackson SH (2005) Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes. Am J Hypertens 218:220–226CrossRef

36.

Title LM, Ur E, Giddens K, McQueen MJ, Nassar BA (2006) Folic acid improves endothelial dysfunction in type 2 diabetes—an effect independent of homocysteine-lowering. Vasc Med 11:101–109CrossRefPubMed

37.

van Etten RW, de Koning EJ, Verhaar MC et al (2002) Impaired NO-dependent vasodilation in patients with type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 45:1004–1010CrossRefPubMed

38.

Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA (1997) Hyperhomocysteinaemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 95:1119–1121PubMed

39.

Antoniades C, Shirodaria C, Warrick N et al (2006) 5-Methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 114:1193–1120CrossRefPubMed

40.

Van Hecke MV, Dekker JM, Nijpels G et al (2008) Homocysteine, S-adenosylmethionine and S-adenosylhomocysteine are associated with retinal microvascular abnormalities: the Hoorn Study. Clin Sci (Lond) 114:479–487CrossRef

41.

Brazionis L, Rowley K Sr, Itsiopoulos C, Harper CA, O’Dea K (2008) Homocysteine and diabetic retinopathy. Diabetes Care 31:50–56CrossRefPubMed

42.

Martin A, Komada MR, Sane DC (2003) Abnormal angiogenesis in diabetes mellitus. Med Res Rev 23:117–145CrossRefPubMed

43.

Brem H, Canic T (2007) Cellular and molecular basis of wound healing in diabetes. J Clin Invest 117:1219–1222CrossRefPubMed

44.

Lugue Contreras D, Vargas Robles H, Romo E, Rios A, Escalante B (2006) The role of nitric oxide in the post-ischemic revascularization process. Pharmacol Ther 112:553–563CrossRef

Titel: Folic acid administration reduces neointimal thickening, augments neo-vasa vasorum formation and reduces oxidative stress in saphenous vein grafts from pigs used as a model of diabetes
verfasst von: J. Bloor
N. Shukla
F. C. T. Smith
G. D. Angelini
J. Y. Jeremy
Publikationsdatum: 01.05.2010
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 5/2010
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-010-1680-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2010

Sulphated galactosylceramide

Meta-analysis on insulin treatment for type 2 diabetes: rushed conclusions? Reply to Wägner AM, Mauricio D [letter]

Glucosamine-induced endoplasmic reticulum stress affects GLUT4 expression via activating transcription factor 6 in rat and human skeletal muscle cells

Rat islet cell aggregates are superior to islets for transplantation in microcapsules